Patents by Inventor Jerry Schneider

Jerry Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200214727
    Abstract: A percutaneous nephrolithotomy (PCNL) needle may include a cannula including a shaft and a cannula hub coupled to a proximal end of the cannula shaft. A depth guide may be disposed on an outer surface of the cannula shaft. A stylet may be disposable within the cannula lumen and may include a tapered point at a distal end of the stylet and a stylet hub coupled to a proximal end of the stylet that is configured to be releasably securable to the cannula hub. An adjustable depth stop may be releasably securable to the cannula shaft at a desired position relative to the depth guide, the adjustable depth guide capable of being manipulated between an adjustment configuration in which the adjustable depth guide is moveable relative to the cannula shaft and a secured configuration in which the adjustable depth guide is secured relative to the cannula shaft.
    Type: Application
    Filed: February 28, 2020
    Publication date: July 9, 2020
    Applicant: BOSTON SCIENTIFIC LIMITED
    Inventors: ERIK E. SPERRY, JERRY T. LONG, JR., RONALD CIULLA, TIMOTHY P. HARRAH, AARON K. KIRKEMO, KENNETH P. REEVER, BRANDON W. CRAFT, ELIZABETH A. STOKLEY, SEBASTIAN KOERNER, CHAD SCHNEIDER, ANANT SUBRAMANIAM, ASHISH JAIN, DIPANKA MEDHI, SUMIT MALIK, SUBODH MOREY, BITEN K. KATHRANI, Salman Kapadia
  • Patent number: 10485774
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: November 26, 2019
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20190319067
    Abstract: Aspects relate to an energy harvesting device adapted for use by an athlete while exercising. The device may utilize a mass of phase-change material to store heat energy, the stored heat energy subsequently converted into electrical energy by one or more thermoelectric generator modules. The energy harvesting device may be integrated into an item of clothing, and such that the mass of phase change material may store heat energy as the item of clothing is laundered.
    Type: Application
    Filed: June 27, 2019
    Publication date: October 17, 2019
    Inventors: Summer Schneider, Vikram Malhotra, Marcus Ward, Jerry Wiant
  • Publication number: 20190314044
    Abstract: Irrigation devices, methods, and systems are disclosed. The system comprises a catheter with one or more lumens and an expandable portion. One or more pumps are used to supply a mixture of contrasting and dilating agents in an interior kidney volume and flush a portion of the mixture out of the interior kidney volume. The method comprises placing a catheter into the interior kidney volume through a ureter, occluding a portion of the ureter with a distal end of the catheter, forming an exit port through an exterior kidney surface, flowing the contrasting and dilating agents through the one or more lumens to supply the mixture in the interior kidney volume, and flushing a portion of the mixture out of the exit port.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 17, 2019
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Jerry LONG, Timothy HARRAH, Aaron KIRKEMO, Brandon CRAFT, Elizabeth STOKLEY, Sebastian KOERNER, Chad SCHNEIDER
  • Patent number: 10411066
    Abstract: Aspects relate to an energy harvesting device adapted for use by an athlete while exercising. The device may utilize a mass of phase-change material to store heat energy, the stored heat energy subsequently converted into electrical energy by one or more thermoelectric generator modules. The energy harvesting device may be integrated into an item of clothing, and such that the mass of phase change material may store heat energy as the item of clothing is laundered.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: September 10, 2019
    Assignee: NIKE, Inc.
    Inventors: Summer Schneider, Vikram Malhotra, Marcus Ward, Jerry Wiant
  • Patent number: 10368884
    Abstract: Irrigation devices, methods, and systems are disclosed. The system comprises a catheter with one or more lumens and an expandable portion. One or more pumps are used to supply a mixture of contrasting and dilating agents in an interior kidney volume and flush a portion of the mixture out of the interior kidney volume. The method comprises placing a catheter into the interior kidney volume through a ureter, occluding a portion of the ureter with a distal end of the catheter, forming an exit port through an exterior kidney surface, flowing the contrasting and dilating agents through the one or more lumens to supply the mixture in the interior kidney volume, and flushing a portion of the mixture out of the exit port.
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: August 6, 2019
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Jerry Long, Timothy Harrah, Aaron Kirkemo, Brandon Craft, Elizabeth Stokley, Sebastian Koerner, Chad Schneider
  • Patent number: 10307386
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: June 4, 2019
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20190060264
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: March 15, 2018
    Publication date: February 28, 2019
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9925157
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9925156
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9925158
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 21, 2017
    Date of Patent: March 27, 2018
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9814689
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: November 14, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170319524
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170319523
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170319522
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170304233
    Abstract: The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: November 28, 2016
    Publication date: October 26, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9795578
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: October 24, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9750708
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: September 5, 2017
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider
  • Publication number: 20170042845
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 16, 2017
    Inventors: Ranjan Dohil, Jerry Schneider
  • Patent number: 9511039
    Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: December 6, 2016
    Assignee: The Regents of the University of California
    Inventors: Ranjan Dohil, Jerry Schneider